# FDA WARNING_LETTER - Pro West Marketing Ltd. - Unknown Date

Source: https://www.keypedia.com/records/warning_letter/pro-west-marketing-ltd/390d4b28-38a1-4366-84c6-c8bc672df98b

> FDA WARNING_LETTER for Pro West Marketing Ltd. on Unknown Date. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Pro West Marketing Ltd.
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Summary: The FDA issued a Warning Letter after reviewing numerous websites, including doctorphentermine.com and trusted-tabs.us, which are offering products in violation of the Federal Food, Drug, and Cosmetic Act. The products, such as "Acomplia (Generic)," "Acomplia (Brand)," "Rimonabant," "Viagra (Brand)," "Cialis (Brand)," "Prozac (Generic)," and "Levitra (Brand)," are classified as drugs under section 201(g) of the Act.

The firm is cited for marketing unapproved new drugs, specifically "Acomplia (Generic)," "Acomplia (Brand)," and "Rimonabant," which are new drugs under section 201(p) of the Act. The sale of these products without FDA-approved applications violates sections 301(d) and 505(a) of the Act. Rimonabant (Acomplia) was explicitly rejected for FDA approval due to safety concerns, including neurological and psychiatric side effects.

Additionally, many websites are selling prescription drugs like "Viagra (Brand)," "Cialis (Brand)," "Prozac (Generic)," and "Levitra (Brand)" without requiring a prescription from a licensed practitioner, rendering them misbranded under section 503(b)(1) of the Act and violating sections 301(a), 301(b), and 30

## Related Officers

- [Former FDA Deputy Commissioner](https://www.keypedia.com/people/deborah-m-autor/b16e4745-566a-4102-ae98-d314ad1b61f5)

Company: https://www.keypedia.com/companies/pro-west-marketing-ltd/ff5d4b0d-d9f0-40ac-a8b8-08d95582cf4b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c